Use of paliperidone in the treatment of Mental Disorders in a Psychiatric patient with reduced liver function

摘要

Refers to a Therapeutic method comprising administering a therapeutically effective amount of a Pharmaceutical composition containing paliperidone a patient with Psychiatric Disorders such as Psychosis, Schizophrenia, bipolar disorder, conduct disorder, Mental Retardation, in Tre, where paliperidone is a quantity of 3% to 20% w / V of the composition.The Composition of paliperidone is not significantly metabolised in the Liver by what may be administered in patients who are at risk of hepatic impairment